We are live on
!
Find out more
NRC
North Run Capital Portfolio holdings
AUM
$43.5M
1-Year Est. Return
38.24%
This Fund
S&P 500
This Quarter
Est. Return
+0.27%
1 Year Est. Return
-38.24%
3 Year Est. Return
+19.43%
5 Year Est. Return
+17.57%
10 Year Est. Return
–
AUM
$1.02B
AUM Growth
+$106M
(+12%)
Cap. Flow
+$107M
Cap. Flow
% of AUM
10.55%
Top 10 Holdings %
Top 10 Hldgs %
62.91%
Holding
30
New
6
Increased
6
Reduced
5
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellium
CSTM
|
+$67.3M |
| 2 |
SFLY
Shutterfly, Inc.
SFLY
|
+$46.4M |
| 3 |
NCR Voyix
VYX
|
+$36.8M |
| 4 |
Visteon
VC
|
+$36.3M |
| 5 |
UTIW
UTI WORLDWIDE INC
UTIW
|
+$26.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INXN
Interxion Holding N.V.
INXN
|
+$86.5M |
| 2 |
AET
Aetna Inc
AET
|
+$46.4M |
| 3 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$35.4M |
| 4 |
ATI
ATI
|
+$12.4M |
| 5 |
GIMO
Gigamon Inc.
GIMO
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 26.18% |
| 2 | Healthcare | 16.84% |
| 3 | Financials | 15.07% |
| 4 | Materials | 9.91% |
| 5 | Technology | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Visteon
VC
$2.79B
| $98.2M | 9.63% |
935,000
+345,000
| +58% | +$36.3M |
|
2
Brookdale Senior Living
BKD
$3.49B
| $88.5M | 8.68% |
2,550,000
+374,000
| +17% | +$13.8M |
|
3
Citizens Financial Group
CFG
$30.3B
| $69.5M | 6.81% |
2,543,831
| – | – |
|
|
4
ATI
ATI
$25.6B
| $68M | 6.67% |
2,250,000
-375,000
| -14% | -$12.4M |
|
5
Macy's
M
$6.53B
| $67.5M | 6.62% |
1,000,000
+250,000
| +33% | +$16.9M |
|
6
Teva Pharmaceuticals
TEVA
$40.8B
| $53.2M | 5.22% |
900,000
+150,000
| +20% | +$9.25M |
|
|
7
Constellium
CSTM
$3.76B
| $50.6M | 4.97% |
+4,279,665
| New | +$67.3M |
|
8
The Mosaic Company
MOS
$7.03B
| $50.4M | 4.94% |
1,075,000
| – | – |
|
|
GIMO
9
DELISTED
Gigamon Inc.
GIMO
| $47.8M | 4.69% |
1,450,000
-350,000
| -19% | -$10.3M |
|
|
SFLY
10
DELISTED
Shutterfly, Inc.
SFLY
| $47.8M | 4.69% |
+1,000,000
| New | +$46.4M |
|
|
ETFC
11
DELISTED
E*Trade Financial Corporation
ETFC
| $47.2M | 4.63% |
1,575,000
-1,205,000
| -43% | -$35.4M |
|
|
NRF
12
DELISTED
NorthStar Realty Finance Corp.
NRF
| $44.1M | 4.33% |
1,387,500
+412,500
| +42% | +$14.8M |
|
13
General Motors
GM
$80.4B
| $43.5M | 4.27% |
1,305,000
| – | – |
|
14
DigitalBridge
DBRG
$2.93B
| $37M | 3.63% |
500,000
| – | – |
|
|
15
NCR Voyix
VYX
$1.14B
| $36.7M | 3.6% |
+1,988,600
| New | +$36.8M |
|
|
UTIW
16
DELISTED
UTI WORLDWIDE INC
UTIW
| $27.5M | 2.7% |
+2,750,000
| New | +$26.5M |
|
17
MasTec
MTZ
$21.1B
| $26.5M | 2.6% |
+1,334,496
| New | +$24.9M |
|
18
Cooper-Standard Automotive
CPS
$523M
| $26M | 2.55% |
422,852
| – | – |
|
|
ALIM
19
DELISTED
Alimera Sciences
ALIM
| $15.9M | 1.56% |
229,884
+31,551
| +16% | +$2.18M |
|
|
XXIA
20
DELISTED
Ixia
XXIA
| $15.9M | 1.56% |
1,275,000
-125,000
| -9% | -$1.56M |
|
21
Crocs
CROX
$6.14B
| $15.4M | 1.51% |
1,047,188
-249,203
| -19% | -$3.52M |
|
|
RP
22
DELISTED
RealPage, Inc.
RP
| $11.9M | 1.17% |
+625,898
| New | +$12.1M |
|
|
NWY
23
DELISTED
New York & Co Inc
NWY
| $10.7M | 1.05% |
3,995,973
| – | – |
|
24
EyePoint Inc
EYPT
$1.03B
| $8.08M | 0.79% |
214,409
| – | – |
|
|
PHLT
25
DELISTED
Performant Healthcare Inc
PHLT
| $5.99M | 0.59% |
1,850,000
| – | – |
|
Similar funds
ACM
HA
JI
CCS
BGP
EOCM
SJIA
LN
North Run Capital's Q2 2015 Portfolio in Review
As of Q2 2015, North Run Capital held 30 positions worth $1.02B, up 12% from $914M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
North Run Capital deployed $107M of net new capital in Q2 2015, opening 6 new positions and adding to 6 existing holdings. Its largest new stake was Constellium: 4,279,665 shares worth $50.6M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was E*Trade Financial Corporation, an estimated $35.4M trimmed.
- North Run Capital's largest Q2 2015 buy was Constellium: 4,279,665 shares worth $50.6M.
- North Run Capital added most to Visteon in Q2 2015, an estimated $36.3M increase.
- North Run Capital's biggest Q2 2015 reduction was E*Trade Financial Corporation, cutting an estimated $35.4M.
- North Run Capital fully exited Interxion Holding N.V. in Q2 2015, selling an estimated $86.5M.
- North Run Capital's ten largest holdings make up 63% of its $1.02B portfolio in Q2 2015.
- North Run Capital opened 6 new positions and closed 4 in Q2 2015.
- North Run Capital's portfolio value rose 12% quarter-over-quarter to $1.02B.
Based on North Run Capital's 13F filing for Q2 2015, filed 14 Aug 2015.